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Viruses enter the body through two main surfaces --- the skin and the mucosal epithelia. These surfaces are covered by epithelial cells that are organized into complex structures ([Box 1](#Sec2){ref-type="sec"}), and this epithelial organization often dictates the mechanisms of viral entry and translocation.

In this review, we explore the strategies that viruses have evolved to translocate across the epithelial barrier and to act as pathogens, according to the target-cell structure and the nature of the virus. To understand these mechanisms, we first map the pathways of viral entry. Then we describe, at the molecular level, the cell receptors that allow viral attachment and entry into the cell, as well as the viral proteins that interact with --- and subvert --- these receptors, which allows the virus to cross the cell membrane.

Our understanding of host--virus interactions at the molecular level has allowed the characterization of many viral receptors at the epithelial surface. The accepted model of viral entry that is achieved using a unique viral receptor has been challenged. Instead, viruses are now thought to use host-cell molecules --- which are referred to as attachment receptors or \'co-receptors\' --- in addition to the protein receptor, which is often renamed the \'principal\' receptor. The dynamics of these receptors in the membrane is crucial because, on binding of the virus, receptors can be recruited to or excluded from transiently organized glycosphingolipid-rich membrane microdomains, which are known as lipid [RAFTS](#Glos2){ref-type="list"}.

An important class of attachment receptors has emerged recently --- namely the carbohydrate chain of [PROTEOGLYCANS](#Glos1){ref-type="list"} and epithelial-membrane [GLYCOSPHINGOLIPIDS](#Glos3){ref-type="list"} ([Fig. 1](#Fig1){ref-type="fig"}). There is growing recognition of the functional importance of these biomolecules, as shown by the emergence of the field of \'glycomics\', or \'the sugar code\'^[@CR1]^. Indeed, oligosaccharides transfer information to complementary effector molecules, and the virus acts as a [LECTIN](#Glos4){ref-type="list"} by binding the carbohydrate as an attachment receptor. Owing to the nature of the lectin--sugar interaction (namely charge-transfer processes that are facilitated by networks of hydrogen-bond formation), environmental factors are important. These factors relate to the characteristics of the mucosal surface, which has numerous carbohydrate groups protruding into the aqueous environment and a high ionic strength.This high ionic strength is due to the charged surface lipids and their counterions. On the viral oligomeric peptide, the lectin site is characterized by the charged amino acids and the aromatic tryptophan that surrounds the galactose ring.Figure 1Proteoglycans and glycosphingolipids.**a** \| Proteoglycans are proteins that are classified by a post-translational attachment of polysaccharide glycosaminoglycan moieties, which are each composed of repeating disaccharide units. The ubiquitously expressed glycosaminoglycan heparan sulphate (shown here) is highly polymorphic, and its sulphated structural motifs are primarily responsible for its protein binding and regulatory properties. **b** \| Glycosphingolipids are anchored in the outer leaflet of the plasma-membrane bilayer by their common hydrophobic backbone, ceramide, which consists of a fatty-acid chain linked to the sphingosine base. The hydrophilic carbohydrate parts of neutral glycosphingolipids and gangliosides protrude into the extracellular space and partially cover the cell surface. GalNAc, (OSO~3~), *N*-acetyl galactosamine sulphate; GlcNSO~3~, glucosamine sulphate; GlcUA, glucuronic acid; IdUA (OSO~3~), iduronic acid sulphate.

**Viral pathways in the epithelial barrier**

Viruses have evolved several pathways to initiate entry through epithelial barriers. Viruses can enter and infect epithelial cells by accessing the cell cytosol using one of two mechanisms --- direct entry at the epithelial plasma membrane, or entry through the epithelial endocytic pathway^[@CR2]^. By contrast, some viruses do not need to infect epithelial cells to spread --- they are internalized by epithelial cells and cross the epithelial barrier using [TRANSCYTOSIS](#Glos5){ref-type="list"} ([Box 1](#Sec2){ref-type="sec"}), as has been described recently for the human immunodeficiency virus (HIV)^[@CR3],[@CR4]^.

In viruses, the genome is surrounded either solely by a capsid (\'naked\' virus), or by both a capsid and a membrane (\'enveloped\' virus; [Box 2](#Sec3){ref-type="sec"}). We know much about the entry mechanism of enveloped viruses, but the mechanism by which naked viruses penetrate epithelial cells is far less well understood. Nevertheless, the route by which viruses enter and then infect or cross epithelial cells is not dictated solely by whether or not the virus is enveloped^[@CR2],[@CR5]^, and the three main modes of entry are summarized in the text below ([Table 1](#Tab1){ref-type="table"}).Table 1Viral receptors on epithelial cells

***Endocytosis and transcytosis (without infection).*** Several enveloped and naked viruses, such as HIV-1 ([Fig. 2](#Fig2){ref-type="fig"}) and poliovirus, cross simple epithelial cells by rapid transcytosis without infection. They are released --- and are still infectious --- at the pole of the cell that is opposite to their pole of entry, and this enables the virus to spread in the submucosa.Figure 2Entry of HIV into a polarized epithelial cell by transcytosis.Cell-free human immunodeficiency virus (HIV) or infected cells encounter a mucosal surface ([Box 4](#Sec5){ref-type="sec"}). Both contain viruses that use either the chemokine receptor CCR5 (R5 virus; found in most acutely infected patients, and therefore thought to be the main vector of infection) or CXCR4 (X4 virus; found later in patients, as the disease progresses) for fusion and/or infection. In the upper small intestine, galactosyl-ceramide (GalCer)^+^/CCR5^+^/CXCR4^−^ epithelial cells endocytose cell-free R5 virus at the lumenal surface in a galactosyl ceramide/CCR5-receptor-mediated mechanism, whereas cell-free X4 viruses cannot enter these CXCR4^--^ epithelial cells^[@CR4]^. Alternatively, R5 (or X4)-infected [MONONUCLEAR CELLS](#Glos11){ref-type="list"} bind to the epithelial cell and induce the polarized budding of newly formed R5 (or X4) viruses, which are rapidly endocytosed through GalCer that is present in raft microdomains^[@CR3],[@CR91]^. HIV transcytoses across epithelial cells to the serosal surface, where fusion of the transcytotic vesicles releases virus into the [LAMINA PROPRIA](#Glos12){ref-type="list"}. Here, R5 viruses infect the CCR5^+^/CXCR4^+^/CD4^+^ lamina propria T lymphocyte, but not the CCR5−/CXCR4−/CD4^+^ intestinal macrophage^[@CR93]^. By contrast, the infection of intestinal CXCR4^+^/CD4^+^ T cells by X4 viruses that are transcytosed from X4-infected cells is blocked by stromal-cell-derived factor (SDF)-1 that is present in the mucosa^[@CR94]^. The ability of primary human M cells to translocate R5 or X4 HIV remains to be clarified.

The Epstein--Barr virus (EBV) uses a more complicated strategy. EBV forms a complex with mucosal immunoglobulin (Ig)A that is specific for gp350, a viral surface protein that is present in latently infected people. The complex binds to the [POLY-IMMUNOGLOBULIN RECEPTOR](#Glos6){ref-type="list"} at the basal surface of epithelial cells, and is endocytosed and delivered apically without infection^[@CR6]^. By contrast, in non-polarized cells, the entry of IgA--EBV leads to infection. Two EBV replicative proteins can stimulate the production of anti-EBV IgA^[@CR7],[@CR8]^, thereby contributing to the development of disease in latently infected people.

Finally, Peyer\'s patches --- specific lymphoid areas of the gastrointestinal tract --- are covered by specialized epithelial cells, which are known as [M CELLS](#Glos7){ref-type="list"}. These patches might be one portal for the mucosal entry of poliovirus^[@CR9]^, HIV-1^[@CR10]^ and reovirus^[@CR11]^, by transcytosis across M cells in a receptor-mediated fashion.

***Polarized surface entry and infection by fusion.*** Viruses can penetrate epithelial cells at the epithelial-cell plasma membrane directly after attachment and fusion. In polarized monostratified epithelium --- where the plasma membrane is divided into two domains that have a different lipid and protein composition and different membrane dynamics --- viruses usually attach and penetrate the cell cytosol preferentially at the restricted pole of the epithelial cell. Some enveloped viruses attach to, and fuse with, the epithelial-cell apical membrane^[@CR12],[@CR13],[@CR14]^, whereas other enveloped viruses^[@CR15]^ attach to, and fuse with, the basal membrane. Importantly, viruses from the same family do not always show the same polarity of entry^[@CR14],[@CR16],[@CR17]^. This is due, in part, to the use of different cell receptors. However, some viruses such as poliovirus can enter at both the plasma membrane and through the endocytic pathway^[@CR18],[@CR19]^ (see below).

***Endocytosis and endosomal fusion with infection.*** Both enveloped and naked viruses can enter epithelial cells by endocytosis, and they usually penetrate the host-cell cytosol by fusion from an [ENDOSOME](#Glos8){ref-type="list"}. This mode of entry makes use of specific endosomal conditions such as low pH or a high concentration of calcium.

In polarized monostratified epithelium, the polarity of viral entry is a determinant for the outcome of an infection, as polarity differentially influences the processing and sorting mechanisms in apical and basolateral endosomes. However, the nature of the experimental system can change the polarity of viral entry^[@CR20]^ ([Box 3](#Sec4){ref-type="sec"}). Some enveloped viruses, such as influenza virus types A and C, bovine coronavirus^[@CR21]^ and hepatitis A virus (HAV)^[@CR22]^, are endocytosed at the apical pole of polarized epithelial cells, whereas vesicular stomatitis virus (VSV), which is also enveloped, is endocytosed basolaterally^[@CR2]^. For all of these viruses, however, access to the cytosol from the endosome is pH dependent.

Other viruses can enter by endocytosis at either of the poles in epithelial cell lines^[@CR23]^, but each route results in a specific infection outcome. Factors that dictate which entry pathway is used by the virus include differences in the interactions between cellular receptors and viral proteins (see below). For example, the infection of pigmented retinal epithelial cells by enveloped primary herpes simplex virus (HSV) and human cytomegalovirus (HCMV) occurs by endocytosis^[@CR24],[@CR25],[@CR26]^ at either one of the poles followed by a pH-independent translocation into the cytoplasm. The outcome is either efficient viral replication followed by host-cell lysis, or, alternatively, latent infection. In the latter case, reactivation of the latent viral genome might then occur, and lead to the infection of nearby sensory neurons and the release of new virions. These virions can then re-enter epithelial cells --- but now in an highly polarized manner --- by fusion at the basolateral pole^[@CR27]^. Naked adeno-associated virus (AAV)-2 enters airway epithelial cells essentially basolaterally by receptor-mediated endocytosis^[@CR28]^. Its single-stranded (ss)DNA is then converted to a circular genome, and its polarity of entry is reinforced by a post-endocytic barrier. By contrast, AAV-2 that enters at the apical pole by a receptor-independent mechanism gives rise to persistent ssDNA that is arrested in a transcriptionally inactive form. The ubiquitin--proteasome pathway, which is involved in the regulation of endocytosis^[@CR29]^, is instrumental in this arrest^[@CR30]^.

In pluristratified epithelia or immature gastrointestinal cells, which lack [TIGHT JUNCTIONS](#Glos9){ref-type="list"}, viral entry is not polarized. Instead, the viruses make use of various endocytic pathways ([Box 1](#Sec2){ref-type="sec"}). Filovirus, influenza virus, simian virus 40 (SV40) and measles virus are endocytosed after clustering in transient raft membrane microdomains^[@CR31],[@CR32],[@CR33],[@CR34],[@CR35]^. Some enveloped viruses, such as the Semliki Forest virus (SFV) and Sindbis virus, as well as some naked viruses, including Jamestown Canyon (JC) polyoma virus, parvovirus, adenovirus-2, two of the picorna viruses --- human echovirus-1 (E-1) and the minor group of human rhinoviruses (HRV) --- and foot and mouth disease virus (FMDV), use receptor-mediated endocytosis through the [CLATHRIN-COATED-VESICLE](#Glos10){ref-type="list"} pathway^[@CR36],[@CR37],[@CR38],[@CR39],[@CR40]^.

Once they are in endosomes, the surface proteins of viruses such as influenza, FMDV, VSV, Sindbis virus or SFV undergo a conformational change that is dependent on a mildly acidic pH, and they can then disrupt the endosomal membrane. Alternatively, other viruses, such as the poliovirus^[@CR18],[@CR19]^ and the major group of HRV^[@CR41]^, translocate from the endosome into the cell cytosol in a pH-insensitive manner, before gaining access to the lysosome --- a compartment that is deeper in the endocytic pathway^[@CR19],[@CR41]^. A Ca^2+^-dependent, but pH-independent, endocytosis and virus-uncoating model has been proposed for the rotavirus^[@CR42]^ that would apply equally to other viruses, whether they are enveloped or naked.

**Multiple viral receptors: a new model**

The differences in the viral-entry pathways are due largely to the nature of the molecular interactions between the viral components and target-cell receptors. Viral pathogenesis arises from mechanisms that have been developed to block or abuse normal cell processes and, as with bacteria^[@CR43]^, the surface proteins of enveloped or naked viruses bind to host-cell molecules that have receptor functions. So, viruses mimic the natural ligand of these receptors and interfere with their signalling to promote viral entry into the cell and the spread of infection ([Box 4](#Sec5){ref-type="sec"}).

The classical concept of viral receptors has been superseded by new data, which indicate that the binding and entry of viruses is a multi-step process that involves the recognition of, and attachment to, the epithelial-cell surface. This is followed either by penetration of the host-cell cytosol, with infection of the cell, or by transcytosis. Each step involves many host-cell receptors. These receptors range from ubiquitous cell-surface-associated carbohydrate moieties of membrane glycoproteins, proteoglycans or glycolipids --- which are inserted in the dynamic bilayer of the target-cell membrane and usually act as attachment receptors --- to cell-specific transmembrane proteins, which can mediate numerous different steps. These many steps are not independent of each other, but their spatio-temporal sequence in the process of viral infection is difficult to assess. Indeed, at the molecular level, the kinetics of each virus--host-cell interaction is dependent on its association constant, the concentration of viral ligands and of host-cell receptors that are available to interact at any given moment, and the nature of the target cell.

To attach to the surface of the target cell, an increasing number of enveloped or naked viruses have been described as acting as lectins, by using a peptide of their envelope or capsid proteins, respectively, that has a lectin site. They compete with endogenous lectins to bind epithelial-cell-surface carbohydrates, which act as attachment receptors. Viral surface proteins are multimeric, they have several lectin sites, so they can interact with several receptor molecules at a time at the host-cell surface. Such clusters of lectin sites have a much higher affinity for oligosaccharides than their monomeric counterparts^[@CR44]^. This multimeric interaction interferes with lipid organization and dynamics, and stabilizes raft microdomains at the epithelial-cell membrane. The lipids in these domains differ from other membrane lipids in their lateral diffusion in the membrane, and they can be separated *in vitro,* owing to their insolubility in detergent. The rafts are small, mobile, unstable and they probably fluctuate in their size and composition as a result of molecular interactions at the cell surface.

Attachment receptors and viral receptors can be recruited to, or excluded from, membrane microdomains such as rafts, clathrin-coated pits or [CAVEOLAE](#Glos13){ref-type="list"}^[@CR5],[@CR45]^. This remodelling of the host-cell membrane is a determinant of the mechanism of virus entry and signal transduction in the host epithelial cell^[@CR46]^.

**Surface carbohydrates as attachment receptors**

The carbohydrate moiety of host-cell glycoproteins, glycosphingolipids and proteoglycans has emerged as a widely used virus-attachment receptor^[@CR47]^.

***Sialyloligosaccharides.*** Influenza virus contains two major surface proteins that are involved in viral entry --- [haemagglutinin](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=18073254&dopt=GenPept) and [neuraminidase](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=24286065&dopt=GenPept) --- which bind and cleave [SIALYLOLIGOSACCHARIDE](#Glos14){ref-type="list"}, respectively. Balanced haemagglutinin and neuraminidase activities are crucial for efficient viral binding to the cell surface, and for viral replication. Influenza virus haemagglutinin is one of the best-known viral lectins. Its trimeric organization increases its affinity for sialyloligosaccharide and allows the virus to bind to the surface of the epithelial cell^[@CR21]^. The epithelial molecules that contain this sialyloligosaccharide carbohydrate receptor remain unknown, although they could be glycoproteins or glycosphingolipids^[@CR48]^. On endocytosis of the influenza virus, haemagglutinin is cleaved into haemagglutinin 1 and haemagglutinin 2. Whereas low endosomal pH exposes the haemagglutinin 2 fusion-peptide domain, haemagglutinin 1 mediates viral fusion with the endosomal membrane^[@CR48]^. Similarly, human JC virus^[@CR49]^ and Sendai^[@CR50]^ virus, as well as sialyloligosaccharide-dependent strains of rotavirus^[@CR20]^ and reovirus, also attach themselves to epithelial cells through sialyloligosaccharides, which are either from glycosphingolipids^[@CR51]^ or proteoglycans^[@CR52]^.

***Glycosphingolipids.*** Several enveloped and naked viruses have recently been shown to interact specifically with a defined carbohydrate moiety of glycosphingolipids ([Fig. 1](#Fig1){ref-type="fig"}; [Table 1](#Tab1){ref-type="table"}). Glycosphingolipids --- which are characteristic components of eukaryotic plasma membranes --- are a highly polymorphic class of lipids and are principal components of the apical plasma membrane of epithelial cells in the gastrointestinal and urinary tracts, myelin and neuroepithelial cells^[@CR53]^. Glycosphingolipids are anchored in the outer leaflet of the plasma membrane bilayer by their common hydrophobic backbone, ceramide, which consists of a fatty-acid chain that is linked to the sphingosine base. The hydrophilic oligosaccharide residues of neutral glycosphingolipids and gangliosides protrude into the extracellular space and, together with the membrane glycoproteins and proteoglycans, they constitute the glycocalyx of the cell surface^[@CR54]^.

The multimeric glycoprotein subunits gp41 (Refs [@CR55]) and gp120 (Refs [@CR3],[@CR58]) of the HIV-1 envelope both attach to the cell-membrane glycosphingolipid, galactosylceramide. Indeed, [D]{.smallcaps}-galactose is particularly eligible for stacking to the aromatic ring system of gp41 owing to the van der Waals interactions and the presence of a set of polarized C--H bonds (C--H/π-electrons) on one side of the galactose ring. Interestingly, HIV-1 and herpesvirus can enter neural cells (which are also polarized) and mucosal epithelial cells, both of which are rich in glycosphingolipids^[@CR59]^. HIV-1 (Ref. [@CR56]), naked Ebola and Marburg viruses (through their capsid proteins) and measles virus^[@CR31],[@CR32]^ require glycosphingolipids to be assembled in rafts for virus attachment and entry into the epithelial cell. This virus--cell interaction, which involves several species of viral surface protein, probably stabilizes raft microdomains, allowing signal transduction in the epithelial cell and endocytosis of the virus. A galactosylceramide/sphingomyelin-binding motif, which is similar to that found in HIV-1 gp120, is also found on prion protein and the amyloid-β peptide that is involved in Alzheimer\'s disease^[@CR60]^.

***Proteoglycans.*** Another class of carbohydrate attachment receptors used by viruses are found on proteoglycans. Proteoglycans are proteins that are classified by the post-translational attachment of polysaccharide [GLYCOSAMINOGLYCAN](#Glos15){ref-type="list"} moieties ([Fig. 1](#Fig1){ref-type="fig"}). Glycosaminoglycan chains provide the initial docking sites for viruses to bind to eukaryotic cells. The ubiquitously expressed glycosaminoglycan [HEPARAN SULPHATE](#Glos16){ref-type="list"} is highly polymorphic, and its sulphated structural motifs are responsible primarily for its protein binding and regulatory properties, as shown recently^[@CR61]^ for respiratory syncytial virus (RSV).

During the past decade, proteoglycans have emerged as key players in the regulatory network of the cell^[@CR62]^. Depending on the length of the glycosaminoglycan chain, and on the sulphated structural motifs, a single glycosaminoglycan chain can bind many viral ligands on a single virion^[@CR62]^. As the cell attachment receptors for numerous enveloped and naked viruses, the glycosyl epitopes of the epithelial-cell-surface proteoglycans mediate virus adhesion, in turn initiating signal transduction as described for the [GLYCOSYNAPSE](#Glos17){ref-type="list"}^[@CR54]^.

HSV-1 uses glycosaminoglycan as a receptor for entry into epithelial cells as well as into primary neuronal cells. There are five HSV-1 glycoproteins --- [gB](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629408&dopt=GenPept), [gC](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629425&dopt=GenPept), [gD](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629447&dopt=GenPept), [gH](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629402&dopt=GenPept) and [gL](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629381&dopt=GenPept) --- and two of these (gB and gC) mediate the attachment of the virus to cellular heparan sulphate^[@CR47],[@CR63]^. Human herpesvirus 8 (HHV-8), which is associated with Kaposi\'s sarcoma, has a broad cellular tropism that includes epithelial cells. This broad tropism might be due, at least in part, to interaction of the viral surface glycoproteins with heparan sulphate^[@CR64]^. Enveloped Rous sarcoma virus (RSV)^[@CR65]^ and adenovirus-2 and -5 (Ref. [@CR66]), as well as several naked viruses including echovirus, AAV-2, human papilloma virus (HPV)-16, HPV-33 and FMDV (Refs [@CR30],[@CR40],[@CR67]), interact with heparan sulphate proteoglycans, which facilitates the attachment and infectivity of the virus. The use of heparan sulphate as an alternative receptor is likely to be the result of an adaptation to growth in cell lines^[@CR71]^.

Paradoxically, the binding of a virus to heparan sulphate might prevent the virus from reaching the cell surface. Indeed, heparan sulphates are present in proteoglycans in the extracellular matrix, and these non-cellular matrix structures can bind viruses. The basal lamina, for example, is a barrier to the spread of HSV-1 from, and back into, epithelial cells. In addition, certain bodily fluids contain heparin, heparan sulphate and heparin-binding proteins, all of which can compete with and inhibit the binding of viruses to cell-surface heparan sulphate^[@CR72]^.

Finally, the glycosylation state of epithelial-cell-surface proteins and lipids varies with the differentiation, ageing and activation of the cell, and such modulation of surface carbohydrates has an evident effect on the susceptibility of epithelial cells to viral infection^[@CR54]^.

**Protein receptors for attachment and infection**

Several classes of protein receptor, which often show a polarized distribution, are used opportunistically by viruses to attach to and infect cells. A protein receptor either mediates these sequential steps by itself, or it has to cooperate with attachment receptors. As mentioned above, few studies describe the mechanism of such cooperativity.

***Integrins.*** Integrins are a class of surface molecules that are used by several viruses (enveloped and naked) to attach to and infect epithelial cells. One class of integrin, the cellular role of which is to maintain cell--cell contact, is expressed basolaterally in cell culture and in gut tissue adjacent to the tight-junction complex on the basolateral pole. However, other integrins, such as α~2~β~1~, are expressed apically in crypt and villus [ENTEROCYTES](#Glos18){ref-type="list"} throughout the intestine.

Integrins that are expressed at the cell surface bind to ligands that are referred to as disintegrins. These disintegrins contain motifs of several amino acids that are specific to each integrin. One of these motifs --- RGD (arginine--glycine--aspartic acid) --- is specific to a set of integrins that are known as RGD-sensitive integrins. Disintegrin motifs are found in viral surface proteins, which allows the virus to bind integrins, and thereby interferes with the *bona fide* ligand.

A restricted set of RGD-sensitive integrins often seems to be used by viruses^[@CR38],[@CR73]^. Several viruses bind RGD-sensitive integrins in an RGD-dependent manner^[@CR74]^. For example, the RGD motif of the HHV-8 envelope glycoprotein B interacts with integrin-α~3~β~1~ to allow attachment of HHV-8 to (and the infection of) epithelial cells and use of the integrin signalling pathway^[@CR75]^. The RGD-containing capsid protein VP1 of FMDV attaches to the integrin-α~v~β~6~, which is expressed on primary epithelial cells, then uses the signalling pathways that are initiated at the [integrin-β~6~](http://ca.expasy.org/cgi-bin/niceprot.pl?P18564) cytoplasmic domain^[@CR71]^. The RGD-containing capsid protein VP1 of human parechovirus 1 (HPEV-1) also interacts with integrins --- α~v~β~3~ and α~v~β~1~ --- on the epithelial cell surface, but HPEV-1 then enters the host cell through the clathrin-dependent endocytic pathway^[@CR38]^.

As an alternative, viral proteins might use other motifs to bind RGD-sensitive integrins in an RGD-independent fashion (that is, the viral protein does not act as a physiological counter-ligand). For example, rotaviral VP4 protein binds the RGD-sensitive integrin-α~2~β~1~, which is basolaterally expressed (or, alternatively, it binds integrin-α~v~β~3~), as a post-attachment receptor through the GDE(A) (glycine--aspartic acid--glutamic acid/alanine) amino-acid motif of the viral protein^[@CR73],[@CR76],[@CR77]^. When both of these integrins are expressed at the epithelial-cell surface, they work together to promote viral entry^[@CR78]^. The rotaviral VP7 protein interacts with integrin-α~x~β~2~ through a GRP (glycine--arginine--proline) motif, and integrin-α~4~β~1~ through an LVD (leucine--valine--aspartic acid) amino-acid motif^[@CR77]^. Direct interaction between VP4 and VP7 has been observed.

Adenoviruses use also [integrin-α~v~](http://ca.expasy.org/cgi-bin/niceprot.pl?P06756) as a receptor to mediate their endocytosis, but binding of the virus to the integrin activates a signalling pathway that is distinct from the physiological one^[@CR79]^. Echoviruses bind to integrin-α~2~β~1~, and during viral entry, [caveolin 1](http://ca.expasy.org/cgi-bin/niceprot.pl?Q03135) and integrin-α~2~β~1~ co-localize with E-1 capsid proteins and migrate into the perinuclear area in the cell^[@CR80]^.

***Cell-adhesion molecules.*** Other adhesion molecules, such as intercellular adhesion molecule 1 ([ICAM1](http://ca.expasy.org/cgi-bin/niceprot.pl?P05362)), function as viral receptors on epithelial cells. The major group of HRV uses ICAM1 as the viral receptor^[@CR81]^. HRVs have a cleft that encircles the fivefold axes of icosahedral symmetry, which accommodates the amino-terminal domain of ICAM1.

***Cell-junction-associated proteins.*** Another widely used class of receptor consists of components of the epithelial-cell tight junctions. The use of such receptors to penetrate epithelial-cell cytosol at the epithelial cell--cell junction implies that the junction complex is disrupted, with an immediate effect on the integrity of the epithelial barrier. Whereas the interaction of viral components with components of the epithelial tight junction has been described biochemically^[@CR69]^, how viruses access such receptors --- which are \'hidden\' in the tight junction *in vivo* --- is difficult to clarify, despite recent studies on cell lines^[@CR17]^.

Two cell-surface glycoproteins --- the coxsackievirus and adenovirus receptor ([CAR](http://ca.expasy.org/cgi-bin/niceprot.pl?P78310)) and the junction-adhesion molecule ([JAM](http://ca.expasy.org/cgi-bin/niceprot.pl?Q9Y624)) --- were identified as transmembrane components of the tight junction in epithelial cells, as well as being entry receptors for coxsackie virus/adenovirus and reovirus, respectively^[@CR69],[@CR82]^. Owing to the localization of CAR at the tight junction, infection by both adenovirus and coxsackievirus *in vivo* could require the destruction of the tight-junction complex for the virus to be able to access its receptor, as is the case *in vitro*^[@CR82]^. Such destruction might be involved in regulating tissue-specific inflammatory responses to viral infection^[@CR69]^. Coxsackievirus binds CAR through a \'canyon\' at the surface of the virus. By contrast, the terminal knob portion of the fibre protein of human adenovirus (HAdV)-2 (Ref. [@CR68]) binds to CAR. This allows the viral capsid penton base protein to bind cell-surface integrin-α~v~β~5~ and its subsequent endocytosis in clathrin-coated vesicles^[@CR79]^.

[Nectin 1](http://ca.expasy.org/cgi-bin/niceprot.pl?Q15223) (also known as poliovirus-related protein 1 or HveC) is a Ca^2+^-independent cell-adhesion molecule that is localized at cadherin-based intercellular junctions. It is used by α-HSV-1 and α-HSV-2 for entry and infection^[@CR83]^ after attachment to epithelial-cell heparan sulphate proteoglycan. In reovirus infection, human JAM --- an integral membrane protein that organizes the tight junctions of epithelial cells --- binds the head domain of the viral σ1 outer-capsid protein. It binds at the basolateral (serosal) pole of the epithelial layer, after reovirus has undergone transcytosis across M cells^[@CR11]^. JAM functions as a serotype-independent receptor that can mediate virus attachment and infection^[@CR69]^.

***Other classes of polarized receptor.*** Several protein receptors have a polarized distribution, which allows viral entry into epithelial cells, or cell resistance to infection when a virus enters epithelial cells by the opposite pole. Apical viral receptors include the carcino-embryonic antigen family^[@CR84],[@CR85]^, [CD46](http://ca.expasy.org/cgi-bin/niceprot.pl?P15529) (Ref. [@CR13]; together with its co-receptor epithelial [moesin](http://ca.expasy.org/cgi-bin/niceprot.pl?P26038)), and the *N*-aminopeptidase [CD13](http://ca.expasy.org/cgi-bin/niceprot.pl?P15144) (Refs [@CR12],[@CR84]), which can dimerize and probably transduce signals. The glycosylphosphatidylinositol (GPI)-anchored complement regulatory protein [DAF](http://ca.expasy.org/cgi-bin/niceprot.pl?P08174) (decay acceleration factor) is widely used by enteroviruses, including echoviruses, human enterovirus (EV)-70, coxsackievirus types B and A21 (Ref. [@CR45]), as well as other GPI-anchored proteins. These GPI-anchored proteins, which are localized in apical rafts, can be endocytosed by a Rho-GTPase-dependent mechanism ([Fig. 1](#Fig1){ref-type="fig"}). So, as shown recently for E-11, they can mediate internalization of the virus in the endosome before translocation into the epithelial-cell cytosol^[@CR45]^. Molecules that are expressed basolaterally include the transferrin receptor. By contrast, viruses can use non-polarized protein receptors^[@CR27]^, and so they need a polarized carbohydrate co-receptor for entry.

**Conclusions and perspectives**

The interaction between a cellular host and a viral pathogen is an important field of research, both for unravelling polarized membrane trafficking^[@CR86]^ and for understanding epithelial pathology (for example, see [Fig. 3](#Fig3){ref-type="fig"}), with obvious significance for designing anti-viral strategies.Figure 3The physio-pathology of diarrhoea induced by rotavirus.During the first cycle of rotavirus replication in mucosal epithelial cells, the synthesis of rotaviral proteins in the cell cytoplasm leads to an increase in the plasma-membrane permeability to Ca^2+^, to activation of regulatory mechanisms and to an increase in the concentration of Ca^2+^ in the endoplasmic reticulum (ER). The increased concentration of cytosolic Ca^2+^ in infected cells promotes the activation of Ca^2+^-dependent enzymes, which in turn induces cell lysis and the release of viral proteins and viral progeny. Non-structural protein (NSP)-4 might act as a viral enterotoxin on as-yet-uninfected cells to induce secretory diarrhoea through **a** \| Ca^2+^-dependent secretion by intestinal cells, **b** \| Ca^2+^-dependent secretion of peptides and amines to stimulate the enteric nervous system (ENS), and **c** \| further activation of epithelial-cell chloride (Cl^−^) secretion by the ENS. In parallel, released virus infects downstream absorptive cells. This will lead to a massive cell death and, as a consequence, reduction of the absorptive surface of the intestinal epithelium and an osmotic component of diarrhoea^[@CR42]^. Various forms of the virus along the rotavirus-maturation pathway are shown: DLP, double-layer particle; IMP, intramembrane particle; Ins(1,4,5)P~3~, inositol 1,4,5-trisphosphate; PLC, phospholipase C; SERCA, sarcoplasmic/endoplasmic-reticulum Ca^2+^-ATPase; TLP, triple-layer particle.

It seems clear that no real correlation can be made between a family (or even a type) of virus and a defined mechanism of interaction with the epithelial cell. Viruses from families as different as naked and enveloped viruses can use the same attachment receptors^[@CR83],[@CR87]^ (for example, carbohydrates or proteins). Conversely, closely related viruses from the same family might use completely different attachment receptors that will dictate the intracellular fate of the virus^[@CR41],[@CR81]^. Even the same virus might use the same attachment receptor but different protein receptors depending on the type of epithelial cell, which extends its infectious potential^[@CR47]^.

The cellular features of the epithelial target therefore seem to be essential if we are to describe the mechanisms of a viral interaction with an epithelial cell. These features are the epithelial trafficking pathways and the epithelial-specific protein and lipid composition that are associated with their signalling pathways. This description emphasizes how viruses act as pathogens --- that is, by subverting the normal epithelial cell function to their own benefit.

We are just beginning to understand the molecular interactions between viral and cellular components. However, the factors that control the finely regulated specificity that is observed *in vivo* for each virus, for a defined target cell, remain unclear. The signalling that is induced when a virus binds its receptors should be compared with the pathways that are activated when the natural ligands bind these same receptors. Entry receptors for many viruses have now been described, and it will be important to correlate data from both cell lines and [PRIMARY CELLS](#Glos19){ref-type="list"}, despite the pitfalls inherent in each system ([Box 3](#Sec4){ref-type="sec"}). In this regard, studies that use the cell type directly involved in the pathology --- rather than receptor molecules transfected in standard cell-line models --- could help. It will also be important to define the environmental parameters that influence binding of the virus to its receptors, and interaction with co-receptors, especially when considering lectin--sugar interactions. The use of new techniques that involve dynamic fluorescence microscopy will help, both for mapping the viral pathway inside epithelial cells and also for studying signalling in epithelial cells.

The first step of viral attachment to the cell --- through either proteoglycan or glycosphingolipids --- raises the question of the specific role of the glycosyl epitope, not only in viral attachment, but also in further transduction of signals. The final glycosylation state of glycoproteins and lipids varies with cell differentiation, maturation or ageing^[@CR54]^, and it could govern the specificity of the virus--carbohydrate interaction that is involved in viral entry into epithelial cells. Lipid microdomains participate in the clustering of viral proteins on the viral membrane and cell receptors on the cell membranes, which favours virus--cell interactions. The spatio-temporal correlation of the different steps of the virus attachment to carbohydrates of the cell surface, and their further interaction with additional protein cell receptors or co-receptors, remains to be established.

Clearly, epithelia are more than just a physical barrier. They are a dynamic host defence system with sensor molecules, signalling circuits and effector molecules that coordinate and execute a graduated reaction to microbes. We are now on the verge of learning more about the molecules and pathways that are involved in these epithelial responses.

 {#Sec2}

Mucosal surfaces are covered by epithelial cells that are organized into various structures. The surfaces of the rectum, endocervix and gastrointestinal tract are covered by a simple epithelial monolayer (see figure, part **a**), whereas the vagina, exocervix, foreskin and anus show a pluristratified organization (see figure, part **b**). In addition to their protective function, epithelial barriers provide the mucosal immune system with a continuous stream of information about the external environment.

Polarized, simple epithelial cells (see figure, part a) have a plasma membrane that is separated by tight junctions into two clearly distinct domains. The apical domain faces the tract lumen, and the basolateral surface faces the serosal side. Actin and microtubules participate in the establishment and maintenance of cell polarity. In addition, polarized membrane-trafficking pathways achieve polarized vectorial functions. Simple epithelial cells have polarized (apical and basolateral) endocytic pathways, each of which uses a complex succession of compartments^[@CR88]^. These pathways can lead to recycling or degradation, but also to transcytosis --- the selective and rapid transcellular vesicular transport from one pole of the epithelium to the opposite one. Transcytosis works in both directions and controls epithelial barrier function.

Multilayered pluristratified epithelial cells (see figure, part **b**) do not have a polarized plasma membrane or tight junctions. Owing to this \'leakiness\', extracellular molecules or other cell types, such as dendritic cells, are free to diffuse between cells using \'paracellular\' pathways. Various mechanisms can mediate the initial step of endocytosis, including clathrin-coated pits and vesicles, or lipid raft microdomains. Raft-mediated endocytosis includes the caveolae/caveolin pathway as well as two pathways described recently^[@CR89]^, which depend on enzymes of the Rho-GTPase family. GPI, glycosyl phosphatidylinositol.

 {#Sec3}

Most viruses contain two or three elements: the genome, in the form of single-stranded (ss) or double-stranded (ds) DNA or RNA; the capsid, which consists of viral proteins; and, possibly, an envelope, which originates from the host cell and consists of host-cell lipids that are organized as a bilayer. Viral-envelope glycoproteins as well as, in some cases, selected host-cell proteins can be recruited to the envelope. \'Naked\' viruses contain only the genetic material surrounded by the capsid. By contrast, in \'enveloped\' viruses, the genome is surrounded by a capsid and is protected further by the viral envelope.

 {#Sec4}

One important issue in studying viral entry into epithelial cells is the choice of the experimental model. In the case of monostratified epithelia, much work has been done on transformed cell lines, which can form polarized, tight barriers when cultivated on permeable supports. However, the protein--lipid composition and glycosylation of transformed cell lines differ greatly from primary cells. These differences could influence the mechanism of viral entry compared with the situation *in vivo*.

As an alternative, primary cells can be used. However, the purification of primary cells results in the destruction of epithelial-barrier function, and polarity is lost because primary cells cannot re-form tight junctions *in vitro*. Biopsies that are mounted at the interface between two chambers maintain their epithelial architecture and barrier function for a few hours. Recently, sheets of epithelial cells with intact cell junctions have been purified from the gastrointestinal tract, but the lifespan of these cells is less than one day.

A new direction for the experimental models has emerged by taking into account the interaction of epithelial cells with submucosal cells. Pringault\'s group^[@CR90]^ succeeded in reconstructing an epithelial barrier similar to those that cover lymphoid organs, which included M cells. They did this by co-culturing transformed intestinal epithelial cells with primary intraepithelial lymphocytes. Such co-culture systems preserve the barrier function of monostratified primary epithelial cells.

HeLa (cervical carcinoma) cells have been widely used as pluristratified epithelium, which is mainly because they grow well and are easily transfectable. However, they differ considerably from primary cells, which are difficult to maintain in culture as an organized tissue.

 {#Sec5}

Viruses can contact the epithelium as two forms --- as cell-free viral particles or as an infected cell. Most studies have been carried out using cell-free particles. However, the importance of infected cells has been revisited. It is known empirically that target-cell infection is usually more efficient using cell-associated viruses, but the mechanism remains unclear. Recent data on human immunodeficiency virus (HIV)^[@CR3],[@CR91]^ and Epstein--Barr virus (EBV)^[@CR92]^ indicate that, by interacting with the epithelial target cell, infected cells might start to bud newly formed cell-free viral particles. These particles interact differently with epithelial cells than does an isolated cell-free virus inoculum. This might be due to the differences in the viral-envelope composition or in the contact between the infected cell and epithelial cells.

Related links {#Sec6}
=============

DATABASES {#Sec7}
---------

### Entrez {#Sec8}

[haemagglutinin](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=18073254&dopt=GenPept)

[neuraminidase](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=24286065&dopt=GenPept)

[gB](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629408&dopt=GenPept)

[gC](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629425&dopt=GenPept)

[gD](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629447&dopt=GenPept)

[gH](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629402&dopt=GenPept)

[gL](http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=protein&list_uids=9629381&dopt=GenPept)

### Swiss-Prot {#Sec9}

[CAR](http://ca.expasy.org/cgi-bin/niceprot.pl?P78310)

[caveolin 1](http://ca.expasy.org/cgi-bin/niceprot.pl?Q03135)

[CD13](http://ca.expasy.org/cgi-bin/niceprot.pl?P15144)

[CD46](http://ca.expasy.org/cgi-bin/niceprot.pl?P15529)

[DAF](http://ca.expasy.org/cgi-bin/niceprot.pl?P08174)

[ICAM1](http://ca.expasy.org/cgi-bin/niceprot.pl?P05362)

[integrin-α~v~](http://ca.expasy.org/cgi-bin/niceprot.pl?P06756)

[integrin-β~6~](http://ca.expasy.org/cgi-bin/niceprot.pl?P18564)

[JAM](http://ca.expasy.org/cgi-bin/niceprot.pl?Q9Y624)

[LMP1](http://ca.expasy.org/cgi-bin/niceprot.pl?P29362)

[moesin](http://ca.expasy.org/cgi-bin/niceprot.pl?P26038)

[nectin 1](http://ca.expasy.org/cgi-bin/niceprot.pl?Q15223)
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PROTEOGLYCAN

:   An acidic macromolecule that is composed of glycosaminoglycan chains attached covalently to a protein core. Proteoglycans are found in the extracellular matrix, cell surfaces, and intracellular vesicles.

\'RAFT\' MEMBRANE MICRODOMAIN

:   A dynamic assembly of cholesterol and sphingolipids in the plasma membrane that is probably involved in cell signalling.

GLYCOSPHINGOLIPIDS

:   A highly polymorphic class of lipids with a common hydrophobic backbone --- ceramide --- that are composed of a fatty-acid chain linked to the sphingosine base and a hydrophilic oligosaccharide residue that protrudes into the extracellular space.

LECTIN

:   A cell-agglutinating protein of non-immune origin, which binds carbohydrates without modifying them.

TRANSCYTOSIS

:   A rapid and selective vesicular transcellular pathway that is characteristic of polarized epithelia. Cargo is transported from one pole of the cell to the opposite pole. The cargo remains enclosed in transcytotic vesicles, which precludes access to the cytosol and therefore viral infection of epithelial cells.

POLY-IMMUNOGLOBULIN RECEPTOR

:   This receptor is expressed at the basolateral surface of epithelial cells, allowing specific transcytosis towards the apical pole of mucosal dimeric IgA or pentameric IgM. At the apical pole, after cleavage of the extracellular region of the receptor, which is known as secretory component (SC), the mucosal IgA or IgM is released with SC as secretory IgA or IgM, and can act as the first defence against pathogens.

M CELL

:   \'Membranous\' or \'microfold\' cell. This is a specialized epithelial cell covering the lymphoid Peyer\'s patches in the gut. M cells can internalize macromolecules and microorganisms and deliver them to the underlying lymphoid tissue.

ENDOSOME

:   A membranous transport vesicle that is involved in endocytosis.

TIGHT JUNCTION

:   A protein heterocomplex that connects neighbouring simple epithelial cells and controls the barrier function of the tight mucosal surface.

CLATHRIN-COATED VESICLE/PIT

:   An invagination of the plasma membrane that is surrounded by clathrin, a cytosolic protein that is formed by a triskelion of three heavy and three light chains. Triskelions assemble into a polyhedral lattice to form the clathrin coat.

MONONUCLEAR CELLS

:   Lymphocytes, dendritic cells and monocytes/macrophages. These are usually found in the blood, but also in tissues.

LAMINA PROPRIA

:   (chorion). This is formed of conjunctive tissue that is traversed by blood and lymphoid vessels. It supports epithelial cells through the basal membrane.

CAVEOLAE

:   Flask-shaped, cholesterol-rich invaginations of the plasma membrane that contain the protein caveolin. They might mediate the uptake of some extracellular material.

SIALYLOLIGOSACCHARIDE

:   An oligosaccharide chain that is linked to a terminal sialic acid (*N*-acetyl neuraminic acid).

GLYCOSAMINOGLYCAN

:   The polysaccharide moiety of proteoglycans, which is added posttranslationally and is composed of repeating disaccharide units.

HEPARAN SULPHATE

:   One of the glycosaminoglycan parts of proteoglycans, this is a long, polyanionic carbohydrate chain that consists of a repeating disaccharide unit.

GLYCOSYNAPSE

:   A membrane structure that provides a connection between two cells, and is involved in a glycosylation-dependent cell-adhesion/recognition processes.

ENTEROCYTE

:   An intestinal epithelial cell that is organized in monostratified layers.

PRIMARY CELL

:   A cell that is isolated directly from living tissues instead of transformed cells.
